Transforming Medicines Development & Manufacture
The CMAC Strategy document provides a common vision for the CMAC direction, with particular focus on the implementation and translation of our manufacturing research programme.
The 2023 Vision and Implementation Plan is set out across the 4-pillars:
Research Excellence
Outstanding Skills Development
World Class Facilities
Exemplary Translation to Industry
The pharmaceutical industry is dealing with significant change as demands from patients, payers and healthcare systems drive increased complexity in the design, development, manufacturing and supply of future medicines. CMAC, with 8 Tier 1 Pharma companies and a thriving Tier 2 community, has been built on pre competitive, industry led collaboration and is delivering an ambitious and impactful research programme.
Ensuring CMAC delivers research excellence and outstanding skills development, whilst establishing world class facilities and promoting exemplary translation to industry, is critical to sustainable success and a focus for the industry partners.
“The environment is changing with the formation of the UK Research and Innovation body (UKRI), the Medicines Manufacturing Industry Partnership (MMIP) and targeted funding through the Industrial Strategy Challenge Fund, and as such, CMAC is well positioned in providing a clear and influential voice in this new international ecosystem.”
